Kyverna Therapeutics
KYTX
#6971
Rank
โ‚ฌ0.47 B
Marketcap
8,00ย โ‚ฌ
Share price
0.53%
Change (1 day)
121.44%
Change (1 year)

Kyverna Therapeutics (KYTX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ29.96 Million

According to Kyverna Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ29.96 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Kyverna Therapeutics - Total liabilities on balance sheet (from 2022 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ36.57 M-80.43%
2023-12-31โ‚ฌ0.18 B42.25%
2022-12-31โ‚ฌ0.13 B12.93%
2021-12-31โ‚ฌ0.11 B